Ranolazine (C20f8d18 1ed7 4f03 9df2 B0fbf38bb35c 01)
Chemical structure of ranolazine, an active ingredient used in the human prescription drug ranolazine.*
Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 68180-354
3 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 68180-354). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Ndc 68180-354-07ranolazine Extended-release Tablets 500 mgrx Only Container Label: Bottle Of 60 Tablets (C20f8d18 1ed7 4f03 9df2 B0fbf38bb35c 02)
Label for Ranolazine Extended-Release Tablets 500 mg by Lupin Pharmaceuticals, Inc. The label specifies each film-coated extended-release tablet contains 500 mg of ranolazine. It includes storage instructions, manufacturer details in the United States and India, and a package count of 60 tablets.*
Ndc 68180-355-07ranolazine Extended-release Tablets 1000 mgrx Only Container Label: Bottle Of 60 Tablets (C20f8d18 1ed7 4f03 9df2 B0fbf38bb35c 03)
Packaging label for Ranolazine Extended-Release Tablets 1000 mg by Lupin Pharmaceuticals, Inc. The label states each film-coated extended-release tablet contains 1000 mg of ranolazine and includes handling instructions to swallow tablets whole without crushing, breaking, or chewing. The package contains 60 tablets and includes storage and manufacturing information.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
